- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02613780
Refractive Treatment of Early Keratoconus
iDesign Aberrometer for the Refractive Treatment of Early Keratoconus
Keratoconus is a bilateral, progressive corneal degenerative disorder that often leads to significant visual deterioration over time. Corneal collagen crosslinking with riboflavin (CXL) was developed as a treatment to halt the progression of keratoconus and thus negate the need for corneal transplantation. However, the treatment alone has little impact in terms of improving visual function. Photorefractive keratectomy (PRK) is the application of an excimer laser to treat a patient's refractive error, therefore decreasing the dependence on spectacles or contact lenses for improved vision.
Corneal collagen crosslinking combined with photorefractive keratectomy has been explored to partially correct the refractive error in keratoconic patients, whilst simultaneously stabilizing the corneal changes. Recently, the iDesign® Advanced WaveScan Studio (iDesign system; Abbot Medical Optics; Santa Ana, CA) has been launched as the most advanced high-resolution aberrometer. It is capable of mapping highly aberrated corneas for wavefront-guided laser procedures, and represents an important technological advance in treating corneal disease.
The purpose of this single center, prospective pilot study is to assess the safety and efficacy of combined wavefront-guided PRK and CXL in patients with early keratoconus using the iDesign® aberrometer. Results of this pilot study will be used to provide sample size estimates for an extension of the study, which aims to determine whether sequential or same day procedure leads to better outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this pilot study is to assess the visual outcomes of combined wavefront-guided PRK and CXL in Krumeich stage 1 and 2 keratoconic eyes. The investigators will be conducting a prospective study at the University of Ottawa Eye Institute. A total of 24 patients will be enrolled in the study divided into two groups:
Group 1: PRK performed12-18 months after CXL; Group 2: PRK performed or on the same day as CXL
Participants will be followed at regular intervals for 1 year and information regarding visual, refractive, keratometric and higher order aberration outcomes will be collected.
The researchers aim to investigate the safety and efficacy of combined wavefront guided PRK and CXL. Results of this pilot study will used to provide estimates for sample size calculation for an extension of the study, which aims to determine whether sequential or same day procedure leads to better outcomes.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Setareh Ziai, MD, FRCSC
- Email: ziaieye@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Group 1:
1. Patients with confirmed diagnosis of keratoconus in Krumeich stage 1 or 2 who have received crosslinking 12-18 months prior, with follow up of at least 12 months
Group 2:
- Diagnosis of keratoconus confirmed based on clinical examination findings and corneal topography
Evidence of progression of keratoconus occurring over the last 12 months defined as:
i. An increase of maximum keratometry reading by 1 diopter or more (≥ 1 D), or ii. Evidence of clinical progression
- Age between 21 and 60 years
- Eyes satisfying all of Krumeich stage 1 or 2 criteria listed below i. Stage 1: eccentric corneal bulging, myopia, and/or astigmatism <5 D and corneal radius ≤48 D, no corneal opacities ii. Stage 2: myopia and/or astigmatism >5 D and <8 D and/or corneal radius ≤53 D, no central opacities, pachymetry ≥400 μm
Exclusion Criteria:
- Age less than 21 years, or older than 60 years
- Pregnant, or planning to become pregnant, or breastfeeding
- Past history of Herpes Simplex Keratitis or corneal surgery (other than crosslinking)
- Thin Cornea (<425 microns)
- Other corneal disease, corneal scarring
- History of chemical burns to the cornea or known healing problems
- Known allergy to Riboflavin (vitamin B2)
- If patient suffers from nystagmus or any other condition that would render it difficult for the patient to hold a steady gaze
- Very advanced corneal ectasia (beyond Krumeich stage 2)
- Poor visual potential
- Vitamin C supplements within 1 week of the procedure
- Lenticular changes (cataracts)
- Programmed PRK treatment exceeding 50 microns in tissue depth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sequential group
Photorefractive keratectomy will be performed 12-18 months after participants had crosslinking
|
corneal collagen crosslinking with riboflavin
Used to map wavefront aberration in planning photorefractive keratectomy
|
Active Comparator: Simultaneous group
Photorefractive keratectomy and crosslinking will be performed on the same day
|
corneal collagen crosslinking with riboflavin
Used to map wavefront aberration in planning photorefractive keratectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement in best-corrected visual acuity at followups
Time Frame: 1 year
|
Best-corrected visual acuity (BCVA) will be measured in logMAR.
Preoperative BCVA will be compared to BCVA postoperatively and at followups over 1 year using paired t tests.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraoperative and postoperative complications
Time Frame: 1 year
|
Number of patients with unexpected complications, as well as the type of complication will be collected over 1 year of followups.
|
1 year
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20150570-01H
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratoconus
-
The Cleveland ClinicUniversity of MarylandEnrolling by invitationKeratoconus | Keratoconus, Unstable | Keratoconus, StableUnited States
-
Eye Hospital Pristina KosovoActive, not recruitingKeratoconus | Keratoconus of Right Eye | Keratoconus, Unstable, Right EyeKosovo
-
Tianjin Eye HospitalRecruitingScansys, Pentacam, Keratoconus, Subclinical KeratoconusChina
-
Tianjin Eye HospitalActive, not recruitingScansys, Pentacam, Corvis ST, Keratoconus, Subclinical KeratoconusChina
-
Heba Allah Nashaat MohamedAssiut UniversityRecruitingKeratoconus, CollagenEgypt
-
Kent Wellish MDNot yet recruitingKeratoconus, Unstable
-
Kasr El Aini HospitalUnknownProgressive KeratoconusEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedProgressive Keratoconus
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Tianjin Eye HospitalCompletedKeratoconus, StableChina
Clinical Trials on Photorefractive keratectomy
-
Tabriz UniversityCompletedAstigmatismIran, Islamic Republic of
-
Assiut UniversityRecruitingCompare Corneal High Order Aberrations Before and After Stream Light Trans-PRK and Mechanical Photorefractive KeratectomyEgypt
-
Baylor College of MedicineActive, not recruitingHyperopia | High Myopia | Anisometropia | Amblyopia Isometropic | Amblyopia Bilateral | High AstigmatismUnited States
-
Walter Reed Army Medical CenterUnited States Naval Medical Center, San DiegoCompleted
-
Assiut UniversityCompletedMyopia ≤ -6 Diopters or Myopic Astigmatism ≤ -4 DioptersEgypt
-
Assiut UniversityCompleted
-
University of UtahTerminatedTopo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive KeratectomySurgery | MyopiaUnited States
-
Bausch & Lomb IncorporatedCompletedAmetropiaPhilippines
-
Shahid Beheshti UniversityTehran University of Medical Sciences; Negah Eye CenterActive, not recruitingKeratoconus | Corneal Cross-LinkingIran, Islamic Republic of
-
Minia UniversityCompletedMyopia | Refractive SurgerySaudi Arabia, Egypt